Inogen | INGN - Operating Expenses


Inogen reported $49.14M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 150.1M 6.16M Sep/2026
Baxter International USD 6.5B 3.82B Sep/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 4.13B 72M Sep/2026
Cooper Companies USD 844.2M 268.3M Jun/2026
Dexcom USD 990.1M 53.5M Jun/2026
Edwards Lifesciences USD 10.86B 9.64B Sep/2026
Globus Medical USD 835.58M 239.73M Jun/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 652.2M 19.8M Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Orthofix International USD 213.79M 12.36M Dec/2025
Philips EUR 3.75B 147M Jun/2026
ResMed USD 1.01B 83.57M Jun/2026
Steris USD 1.27B 62.5M Sep/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 268.35M 3.7M Jun/2026
Teleflex USD 3.49B 589.18M Sep/2026
X T L Biopharmaceuticals USD 1.1M 175K Dec/2024
Zimmer Biomet Holdings USD 1.72B 110.9M Sep/2026